Literature DB >> 15203254

Torsade de pointes: the clinical considerations.

Ramesh M Gowda1, Ijaz A Khan, Sabrina L Wilbur, Balendu C Vasavada, Terrence J Sacchi.   

Abstract

Torsade de pointes is a form of polymorphic ventricular tachycardia occurring in a setting of prolonged QT interval on surface electrocardiogram. Congenital causes of prolonged QT interval occur in individuals with genetic mutations in genes that control expression of potassium and sodium channels and acquired causes are numerous, predominantly drugs causing prolonged QT interval by blockade of potassium channels. Among the drugs, antiarrhythmic agents most notably quinidine, sotalol, dofetilide and ibutilide have the potential to induce the fatal torsade de pointes. Many non-antiarrhythmic drugs can also cause torsade de pointes. Although it is important to distinguish between the congenital and the acquired forms of long QT syndrome as the later can often be reversed by correction of the underlying disorder or discontinuation of the offending drug, both forms are not mutually exclusive. Clinical considerations and management of torsade de pointes are described.

Entities:  

Mesh:

Year:  2004        PMID: 15203254     DOI: 10.1016/j.ijcard.2003.04.055

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  18 in total

Review 1.  Modulation of the QT interval duration in hypertension with antihypertensive treatment.

Authors:  Jan Klimas; Peter Kruzliak; Simon W Rabkin
Journal:  Hypertens Res       Date:  2015-03-19       Impact factor: 3.872

2.  ECG Diagnosis: Ibutilide-induced Torsade de Pointes.

Authors:  Daphne D Le; Joel T Levis; Nelya Lugovskaya; David R Vinson
Journal:  Perm J       Date:  2019

Review 3.  Genetics of congenital and drug-induced long QT syndromes: current evidence and future research perspectives.

Authors:  Saagar Mahida; Andrew J Hogarth; Campbell Cowan; Muzahir H Tayebjee; Lee N Graham; Christopher B Pepper
Journal:  J Interv Card Electrophysiol       Date:  2013-03-21       Impact factor: 1.900

4.  Double jeopardy.

Authors:  Damien Cullington; Natalie Dunford; Stephen Beer; Neil Hobson; Sudipta Chattopadhyay; Joseph John
Journal:  Indian Heart J       Date:  2013-04-19

5.  Blockade of IKs by HMR 1556 increases the reverse rate-dependence of refractoriness prolongation by dofetilide in isolated rabbit ventricles.

Authors:  Petsy Pui-Sze So; Xu-Dong Hu; Peter H Backx; José Luis Puglisi; Paul Dorian
Journal:  Br J Pharmacol       Date:  2006-06       Impact factor: 8.739

6.  Clinical characteristics of patients with drug-induced QT interval prolongation and torsade de pointes: identification of risk factors.

Authors:  Konstantinos P Letsas; Michalis Efremidis; Stavros P Kounas; Loukas K Pappas; Gerasimos Gavrielatos; Ioannis P Alexanian; Nikolaos P Dimopoulos; Gerasimos S Filippatos; Antonios Sideris; Fotis Kardaras
Journal:  Clin Res Cardiol       Date:  2008-11-24       Impact factor: 5.460

7.  Drug-Induced QT Prolongation And Torsades de Pointes.

Authors:  Matthew Li; Liz G Ramos
Journal:  P T       Date:  2017-07

8.  Clarithromycin-Induced Long QT Syndrome: A Case Report.

Authors:  Mecnun Cetin; Munevver Yıldırımer; Serkan Ozen; Sema Tanrıverdi; Senol Coskun
Journal:  Case Rep Med       Date:  2012-03-26

9.  Torsades de pointes during laparoscopic adrenalectomy of a pheochromocytoma: a case report.

Authors:  Kinge van der Heide; Ann de Haes; Götz Jk Wietasch; Ans Cp Wiesfeld; Herman Gd Hendriks
Journal:  J Med Case Rep       Date:  2011-08-12

10.  Torsade de pointes caused by polypharmacy and substance abuse in a patient with human immunodeficiency virus.

Authors:  Jane M Prosser; Angela Mills; Eugene S Rhim; Jeanmarie Perrone
Journal:  Int J Emerg Med       Date:  2008-08-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.